No one knows your knee—and the pain and discomfort you’re feeling from osteoarthritis—better than you. So when you visit your doctor for a diagnosis of your knee pain, it’s up to you to let the doctor know how you feel and which treatments you would like to try. After all, it’s your knee and you’re the only one who has to live with the results of the treatment.

Before your appointment, print out and answer the SUPARTZ FX Assessment Tool on this website to help you describe your knee pain to your doctor. Also, print out and complete the SUPARTZ FX Knee Pain Tracker on this website to demonstrate how your pain persists over a period of weeks.

If you are diagnosed with knee osteoarthritis, here are some questions you may want to ask your doctor when choosing your treatment:

  • What are the typical treatments that you recommend for knee osteoarthritis patients—and what results do they usually experience?
  • Have you recommended HA or viscosupplementation joint injections to your patients?
  • Which kind of patients tend to benefit from certain types of therapy?
  • Which joint injection treatments do you usually prescribe?
  • Have you ever used SUPARTZ FX for your patients?
  • Would I be a good candidate for SUPARTZ FX?
  • How could SUPARTZ FX help me resume my activities?

The answers to these questions could help you take a more active role to confidently choose the right treatment for your knee so you can get back to being yourself again.

SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to poultry products. SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site. Full prescribing information can be found here or by contacting customer service at